Effect of orlistat on insulin resistance in patients with type 2 diabetes with baseline HbA1c levels ≥8%

被引：0
|
作者：
Rissanen, A
Hollander, P
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1694
引用
收藏
页码：A413 / A413
页数：1
相关论文
共 50 条
  • [1] Efficacy of orlistat in patients with type 2 diabetes with baseline HbA1c, levels ≥8%
    Davidson, JA
    Barnett, A
    [J]. DIABETES, 2002, 51 : A95 - A95
  • [2] Effect of orlistat in patients with type 2 diabetes at differing baseline HbA1c levels
    De Fronzo, R
    Pi-Sunyer, FX
    [J]. DIABETES, 2002, 51 : A412 - A412
  • [3] Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes
    Giugliano, D.
    Esposito, K.
    [J]. DIABETIC MEDICINE, 2011, 28 (02) : 247 - 247
  • [4] Effect of Internet Therapeutic Intervention on HbA1c Levels in Patients with Type 2 Diabetes Treated with Insulin
    Tildesley, Hugh D.
    Mazanderani, Adel B.
    Ross, Stuart A.
    [J]. DIABETES, 2010, 59 : A134 - A135
  • [5] Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline
    McGill, Janet B.
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Birkenfeld, Andreas L.
    Caramori, Maria L.
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Lawatscheck, Robert
    Scott, Charlie
    Rossing, Peter
    FIDELIO-DKD Investigator
    FIGARO-DKD Investigator
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1512 - 1522
  • [6] Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes
    West, Sophie D.
    Nicoll, Debby J.
    Wallace, Tara M.
    Matthews, David R.
    Stradling, John R.
    [J]. THORAX, 2007, 62 (11) : 969 - 974
  • [7] Efficacy of Dapagliflozin in Patients with Type 2 Diabetes Mellitus and Baseline HbA1c=9.0%
    Katz, Arie
    Yeh, Helen
    Sugg, Jennifer E.
    Parikh, Shamik J.
    List, James F.
    [J]. DIABETES, 2014, 63 : A284 - A285
  • [8] Effects of finerenone in patients with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability and duration of diabetes
    McGill, J. B.
    Agarwal, R.
    Anker, S. D.
    Bakris, G. L.
    Filippatos, G.
    Pitt, B.
    Ruilope, L. M.
    Birkenfeld, A. L.
    Caramori, M. L.
    Brinker, M.
    Joseph, A.
    Lage, A.
    Lawatscheck, R.
    Scott, C.
    Rossing, P.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S318 - S318
  • [9] THE IMPACT OF BASELINE HBA1C AND HBA1C TRAJECTORIES ON TIME TO THERAPY ESCALATION IN TYPE 2 DIABETES MELLITUS
    McEwan, P.
    Foos, V
    Larnotte, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A698 - A698
  • [10] Relationship between salivary levels of interleukin-8 and HbA1c in patients with type 2 diabetes
    Shirzaiy, Masoomeh
    Dalirsani, Zohreh
    Peymankar, Payam
    Taherizadeh, Mahboobeh
    [J]. ENDOCRINOLOGY DIABETES & METABOLISM, 2023, 6 (06)
12345